CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![Machine learning, AI-GettyImages-1466280758]( "AI In Clinical Trials: Why Process Orchestration Matters More Than The Model")
AI In Clinical Trials: Why Process Orchestration Matters More Than The ModelDiscover why the future of clinical research depends not just on smarter AI, but on the workflow architecture that connects data, technology, and human judgment.
-
![ai-data-GettyImages-2236890597]( "Who Decides? Navigating AI Governance in Clinical Research")
Who Decides? Navigating AI Governance in Clinical ResearchAI in clinical research poses governance challenges. Clear ownership, consistent policies, and aligned teams help manage risk, ensure compliance, and drive responsible innovation in complex trials.
-
![AI, digital innovation-GettyImages-2202490582]( "Building A Clinical Research AI Governance Framework")
Building A Clinical Research AI Governance FrameworkLearn how structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust while enabling innovation in increasingly data-driven trials.
-
![Scientist Thinking GettyImages-1370154329]( "2026 Annual Completed Clinical Trials Report: Strong Headwinds And Winds Of Change")
2026 Annual Completed Clinical Trials Report: Strong Headwinds And Winds Of ChangeAre your Phase I–III/IV clinical studies prepared for today's regulatory landscape? Learn how leading organizations are addressing compliance, transparency, and data ownership risks.
-
![digital-biomarkers-GettyImages-2246115813]( "How Pharmacometrics Informs Dose Selection And Biomarker Decisions")
How Pharmacometrics Informs Dose Selection And Biomarker DecisionsQuantitative modeling guides early dose and biomarker insights, reducing uncertainty, improving study design, and enabling faster, more confident decisions from first trials to clinical progress.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
-
Scaling Global Vaccine Mega-Trials For A Top Five Pharma4/16/2026
See how high-volume enrollment, dynamic safety data capture, and rapid iteration can support global studies operating under intense timelines and scale.
-
Increasing Participation In World-Class Cancer Research In Northwest Arkansas3/26/2026
Discover how data automation and integrated screening help community cancer centers offer clinical research as a standard care option, ensuring all patients have access to the latest treatments.
-
Improving Clinical Research Efficiency And Access For Underserved Populations3/26/2026
Modernizing data workflows removes geographic barriers to clinical trials, ensuring rural patients access innovative care while reducing administrative burdens on dedicated research staff.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Technology solutions for life sciences that get products to market quickly and efficiently.
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
With ParexelAI™, you're not just optimizing your current development timeline, you're unlocking the ability to run more programs simultaneously across our global network and compress critical timelines. In a landscape where speed to market directly impacts patient outcomes, ParexelAI empowers you to innovate and make a meaningful difference in patients' lives.
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
At inSeption Group, we don’t just crunch numbers—we transform data into confident action. Your trial’s success hinges on how well data is planned, analyzed, and delivered, and we make sure every finding moves your program forward.
In clinical research, data are everything. At inSeption Group, we understand the vital role data management plays in getting life-changing treatments to patients faster.
ProPharma is committed to ensuring clients achieve optimal results. As your Benchling partner, our team of R&D Technology experts will ensure you obtain the most value from your Benchling software investment.
Enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.
CENTRAL LABORATORIES SOLUTIONS
- Advarra eRegulatory Management System Overview
- How AI Is Setting A New Standard In Clinical Development
- Medidata Clinical Data Studio: AI-Assisted Data Reconciliation
- Drive Automation And Efficiency In Your Interim Lock Process
- Introducing Sitetrove Global Patient Insights
- Synthetic Control Arm®: The Smart External Control Arm Solution
- Driving Efficiency And ROI In Clinical Trials
- Wearable Device Comparison Guide: Medical-Grade Or Consumer Device?
- The Next-Generation Of Clinical Trial Data Management And Operations
- An End-To-End Clinical Data Science Solution
VIDEOS
NEWS
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Univo IRB And The Patient View Announce Partnership
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience
- Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe
- Block Clinical Discusses Patient Travel Support With Panel Members